Current Report Filing (8-k)
25 Março 2021 - 8:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): March 19, 2021
SYSOREX, INC.
(Exact name of registrant as specified in
its charter)
Nevada
|
|
000-55924
|
|
68-0319458
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
13880 Dulles Corner Lane
Suite 175
Herndon, Virginia
|
|
20171
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including
area code: 800-929-3871
N/A
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K is intended
to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the
Act:
Title of Each Class
|
|
Trading Symbol
|
|
Name of Each Exchange on Which Registered
|
N/A
|
|
N/A
|
|
N/A
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01
|
Entry into a Material Definitive Agreement.
|
Sysorex, Inc. (the
“Company”), Systat Software, Inc. (“Systat”) and First Choice International Company, Inc. (“Lender”)
entered into a Letter Agreement (“Letter Agreement”) dated as of March 19, 2021, providing for the advance payment
by the Lender of $2,000,000 (“Advance”) to Systat on behalf of the Company. In consideration of the Advance, Systat
agreed it would (a) enter into a Securities Settlement Agreement (“SSA”) with the Company for the cancellation of three
promissory notes owed (or to be owed) by the Company in the aggregate principal amount of $3,300,000 (“Notes One - Three”)
to Systat; and (b) assign a fourth note dated June 30, 2020, in the principal amount of $3,000,000 (“Fourth Note”)
to Lender to be held as collateral pending repayment by the Company of the Advance as further set forth below.
In further consideration
of the Advance, under the terms of an SSA (a form SSA is attached to the Letter Agreement), Systat has agreed that upon the Company’s
issuance of shares of the Company’s restricted common stock to Systat in full satisfaction of the $3,300,000 in promissory
notes and accrued interest owed to Systat, all indebtedness owed to Systat (other than debt arising from the Fourth Note) will
be fully extinguished and cancelled. The number of shares to be issued will be determined at a later date.
The description of
the Letter Agreement is a summary only, is not intended to be complete, and is qualified in its entirety by reference to the full
text of the Letter Agreement, a copy of which is filed herewith as Exhibit 10.1 and which is incorporated herein by reference.
The Company and the
Lender are continuing to negotiate the terms of a loan agreement providing for repayment by the Company of the Advance as well
as the terms of a second SSA to be entered into between the Lender and the Company whereby the Lender will cancel the Fourth Note
on substantially similar terms as will be negotiated between the Company and Systat for Notes One-Three, except that the shares
that are issued by the Company in consideration for cancellation of the Fourth Note shall be held by the Company’s transfer
agent as collateral for the Advance and will only be released to the Lender in the event that the Company does not timely repay
the Advance to Lender inclusive of accrued interest and any fees.
Item 3.02
|
Unregistered Sales of Equity Securities.
|
The
information set forth in Item 1.01 of this Current Report on Form 8-K, to the extent required by this Item 3.02, is incorporated
herein by reference. The shares of common stock that may be issued pursuant to the SSA will be sold and issued without registration
under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemptions provided by Section
4(a)(2) of the Securities Act as transactions not involving a public offering and/or Rule 506 promulgated under the Securities
Act as sales to an accredited investor, and in reliance on similar exemptions under applicable state laws.
The
Company currently has 494,311 shares of common stock outstanding, excluding any shares that may be issued pursuant to the SSA or
previously disclosed pledge arrangements.
Item 9.01
|
Financial Statements and Exhibits.
|
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
SYSOREX, INC.
|
|
|
Date: March 25, 2021
|
By:
|
/s/ Zaman Khan
|
|
Name:
|
Zaman Khan
|
|
Title:
|
Chief Executive Officer
|
2
Sysorex (CE) (USOTC:SYSX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Sysorex (CE) (USOTC:SYSX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
Notícias em tempo-real sobre Sysorex Inc (CE) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Sysorex, Inc.